Alnylam's Founding CEO John Maraganore To Exit The Company
See more from Benzinga
Edwards Lifesciences Says Delta Variant Drove Procedure Deferrals In Q3
Teladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.